Category: yusuf saleeby

Paxlovid, Advertised for Mass Use, Has Contraindications With Hundreds of Drugs

December 13, 2022
AMERICACCP Virusjack askinsJohn Hughesmichael lamPaxlovidPUBLIC HEALTH INFORMATIONritonavirsabine hazanThe Food and Drug Administrationyusuf saleeby
0 Comment

One of the most robustly campaigned and well-known drugs for treating COVID is Paxlovid. Yet the drug’s limited clinical studies and numerous drug interactions raise questions of safety for COVID patients. Approved for Emergency Use Authorization (EUA) in December 2021 and promoted by the Food and Drug Administration (FDA), health officials, and politicians alike, Paxlovid…

Read More

Doctor Shares Alternative Spike Protein Treatments When Go-to Options Fail

November 4, 2022
adaptogensAMERICAautophagyCCP Viruslong COVIDMagnesiummitochondriaoxytocinSARS-CoV-2Spike proteinUSUS Newsvaccine injuryVaccines & Safetyvitamin CVitamin Dyusuf saleeby
0 Comment

Over two years into the pandemic and over a year since the COVID-19 vaccinations rolled out, millions of people are still nursing themselves in the aftermaths as they recover from spike protein injuries, whether it be through COVID-19 or vaccinations. Many doctors put together recommendations on treating long COVID and vaccine injuries based on clinical…

Read More